<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             J Biol Chem. 2007 January 19; 282(3): 1670&#226;&#8364;&#8220;1678. doi:10.1074/jbc.M610500200. <br />  <br />  <br />  <br />                            A Role For Lte1p (a Low Temperature Essential Protein Involved <br />                            Mitosis) Proprotein Processing Yeast Secretory <br />                            Pathway* <br />  <br />                            Xiang Zhao&#226;&#8364;&#161;,&#194;&#167;, Amy Y. Chang&#194;&#182;, Akio Toh-e||, Peter Arvan&#226;&#8364;&#161;,1 <br />                            &#226;&#8364;&#161; Division Metabolism, Endocrinology &amp; Diabetes, University Michigan Medical School, Ann Arbor, <br />                            Michigan 48109 <br />                            &#194;&#167; Sue Golding Graduate Division, Albert Einstein College Medicine, Bronx, New York 10461 <br />                            &#194;&#182; Department Molecular, Cellular, Developmental Biology, University Michigan, Ann Arbor, <br />                            Michigan 48109 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            || Department Biological Science, University Tokyo, Hongo 7-3-1, Tokyo 113-0033, Japan <br />  <br />                            <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                                 We previously identified single gene disruptions Saccharomyces cerevisiae allow <br />                                 enhanced immunoreactive insulin secretion primarily defective Kex2p-mediated <br />                                 endoproteolytic processing. Five eis mutants disrupted established VPS (vacuolar protein sorting) <br />                                 genes, The sixth, LTE1, Low Temperature (&lt;15 &#194;&#176;C) Essential gene encoding large protein with <br />                                 potential guanine nucleotide exchange (GEF) domains. Lte1p functions positive regulator the <br />                                 mitotic GTPase Tem1p, overexpression Tem1p suppresses low temperature mitotic defect <br />                                 lte1. By sequence analysis, Tem1p highest similarity Vps21p (yeast homolog mammalian <br />                                 Rab5). Unlike TEM1, LTE1 restricted mitosis expressed cell cycle. <br />                                 Lte1p function interphase cells largely unknown. Here confirm eis <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-56' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span>phenotype</span> lte1 <br />                                 mutant cells demonstrate defect proalpha factor processing rescued expression of <br />                                 full-<span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> Lte1p C-terminally truncated Lte1p lacking GEF homology domain. Neither <br />                                 overexpression Tem1p 13 structurally related GTPases suppress secretory <br />                                 proprotein processing defect. However, overexpression Vps21p selectively restores proprotein <br />                                 processing manner dependent active GTP-bound form GTPase. By contrast, a <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 vps21 mutant produces synthetic defect lte1 proprotein processing, synthetic <br />                                 growth defect. Together, data underscore link mitotic regulator, Lte1p, protein <br />                                 processing trafficking secretory/endosomal system. <br />  <br />                                              A genetic screen previously performed yeast mutagenized random gene <br />                                              disruptions (by insertion lacZ/LEU2) identify genetically engineered cells exhibiting <br />                                              enhanced immunoreactive insulin secretion (eis,2 derived integrated GAL1 promoter- <br />                                              driven insulin-containing fusion protein called ICFP, Ref. 1). The ICFP comprised the <br />                                              leader propeptide yeast alpha-mating factor contiguous single chain insulin, <br />  <br />  <br />                            *This work supported National Institutes Health Grant DK48280 help Molecular Biology Core U- <br />                            M Diabetes Research Training Center (NIH DK20572). <br />                            1To correspondence addressed: Division Metabolism, Endocrinology &amp; Diabetes, 5560 MSRB2, University of <br />                            Michigan, 1500 E. Medical Ctr Dr., Ann Arbor MI 48109. Tel.: 734-936-5505; Fax: 734-936-6684; E-mail: parvan@umich.edu. <br />                            2The abbreviations used are: eis, enhanced immunoreactive insulin secretion gene; GEF, guanine nucleotide exchange factor; vps, <br />                            vacuolar protein sorting gene; ICFP, insulin-containing fusion protein; lte, low temperature essential gene; mAb, monoclonal antibody; <br />                            CPY, carboxypeptidase Y. <br />                             Zhao et al.                                                                                               Page 2 <br />  <br />  <br />                                          separated Kex2p cleavage site. Cleavage Kex2p-processing site causes insulin <span id='am-4' about='protege:TO' typeof='owl:Thing'>to</span> <br />                                          delivered ultimately vacuole manner requires specific insulin structural <br />                                          features (2). <span id='am-2' about='protege:FROM' typeof='owl:Thing'>From</span> 90,000 transformants originally screened, independent gene <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          disruptions identified. Each eis mutants secrete slightly to <br />                                          dramatically increased amounts unprocessed ICFP, indeed, kex2&#206;&#8221; mutant exhibited <br />                                          maximal immunoreactive insulin secretion (1). Upon analysis, eis mutants <br />                                          vacuolar protein sorting mutants vps8, vps35, vps13, vps4, vps36, which <br />                                          affect protein trafficking impair protein processing Golgi &#226;&#8225;&#8224; endosomal <br />                                          (e.g. Ref. 3). Such outcome explained ability Kex2p other <br />                                          secretory protein processing enzymes (such Ste13p Kex1p) function properly requires <br />                                          continuous recycling Golgi endosomal systems (4). <br />  <br />                                          In article, report eis4 caused disruption gene known LTE1 (5). <br />                                          LTE1 low temperature essential gene product required &lt;13 &#194;&#176;C allow yeast cells <br />                                          advance spindle pole checkpoint mitosis, small GTPase <br />                                          Tem1p essential (6). Lte1p positive regulator Tem1p function (7) overexpression <br />                                          TEM1 rescues cold-sensitive growth arrest lte1 cells (8). Lte1p large, modular- <br />                                          appearing primary structure including small GEF homology domains embedded C- and <br />                                          N-terminal regions (9). Overexpression lte1-mini (truncated lack domains) can <br />                                          suppress cold-sensitive growth arrest lte1D cells, raising possibility Lte1p might <br />                                          GEF Tem1p (10); however, analysis supports hypothesis GEF <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          function Lte1p activates Tem1p (11). Importantly, Tem1p expression becomes <br />                                          significant mitosis (telophase), Lte1p stably expressed cell cycle <br />                                          (12), suggesting possible roles Lte1p interphase cells. <br />  <br />                                          Beginning G1 &#226;&#8224;&#8217; S transition cell cycle, secretory pathway focuses bud <br />                                          site expands bud shall daughter cell (13). Lte1p localization (which is <br />                                          regulated phosphorylation, Ref. 9) normally confined buds growing secretory <br />                                          activity, virtue interactions plasma membrane-associated Ras2p <br />                                          (10) bound cell polarity proteins bud Kel1p and <br />                                          Kel2p (14). Even so, surprising discover lte1 screen revealing secretory <br />                                          protein processing mutants. In present study, sought confirm secretory protein <br />                                          processing defect lte1 mutant cells. The present work highlights importance Lte1p <br />                                          C-terminal region (that includes GEF domain) proprotein processing. We report <br />                                          genetic interactions VPS21 (encoding yeast homolog mammalian Rab5) LTE1, <br />                                          suggesting new role Lte1p protein trafficking secretory/endosomal systems. <br />  <br />                               EXPERIMENTAL PROCEDURES <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Strains Media <br />                                          Standard yeast media genetic manipulations described (15). Strain L5145/MI316 <br />                                          expresses ICFP single chromosomal locus driven GAL1 promoter (1). Strain <br />                                          lte1773 eis4 mutant L5145/pMI316 displaying enhanced immunoreactive insulin <br />                                          secretion random mutagenesis screening (1). The strains employed study, <br />                                          unless stated otherwise, isogenic W303 L3852 (Table 1). <br />  <br />                               Plasmids Molecular Biology <br />                                          pRSGLC TRP1-marked centromeric plasmid (pRS314, Ref. 16) bearing TDH3 <br />                                          promoter (17). The pPD34 plasmid, previously described (8), carries ~9-kb yeast genomic <br />                                          DNA fragment includes entire LTE1 gene. From pPD34, ~6.0 kb NcoI-SphI fragment <br />                                          containing LTE1 coding downstream sequences (but lacking promoter) excised <br />                                          subcloned shuttle vector pSL1180. A cDNA fragment encoding initiator methionine <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                Page 3 <br />  <br />  <br />                                           triple Myc tag fused in-frame directly start codon LTE1. A ~4.5-kb <br />                                           fragment including coding sequence terminator excised SacI inserted <br />                                           appropriate orientation site pYES2 (InVitrogen) produce pYL9, 2-&#206;&#188; plasmid <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           marked URA3, GAL1 promoter controls expression triple Myc-LTE1. <br />                                           pYL9DEV created introducing TGA stop condon EcoRV site LTE1 to <br />                                           produce C-terminally truncated lte11012 mutant. The VPS21 coding sequence was <br />                                           amplified genomic DNA PCR using following primers: GGATCCTTATCTAAGC <br />                                           (which introduces BamHI site, underlined) GTCGACAGATCTATTTATC (which <br />                                           introduces SalI site, underlined). The TEM1 coding sequence amplified genomic <br />                                           DNA PCR using following primers: GGATCCATTAAATTGAGTTAAGC (which <br />                                           introduces BamHI site, underlined) GTCGACTCATGTATTAACGCCC (which <br />                                           introduces SalI site, underlined). Both pTVPS21 pTTEM1 constructed digesting <br />                                           PCR products BamH I SalI followed subcloning respective sites of <br />                                           pRS-GLC. Other plasmids employed study described Table 2. <br />  <br />                                           The single point mutant Vps21p-S21L using QuikChange Site-directed <br />                                           Mutagenesis kit (Stratagene, La Jolla, CA) plasmid-encoded wild-type VPS21 a <br />                                           template pair primers: <br />                                           GGTGAGGCAGCAGTTGGTAAATTGTCAATAGTCCTAAGG and <br />                                           CCTTAGGACTATTGACAATTTACCAACTGCTGCTCACC. The single point mutant <br />                                           Vps21p-Q66L kit employing <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           TGGGACACTGCTGGGCTAGAGAGATTTGCATCTTTAGCA and <br />                                           TGCTAAAGATGCAAATCTCTCTAGCCCAGCAGTGTCCCA mutagenic primers. <br />  <br />                               Filter Blot Assays <br />                                           To assay secretion insulin-containing peptides, cell patches replica-plated onto <br />                                           nitrocellulose filters placed plates containing 2% galactose sole carbon source. <br />                                           After 24&#226;&#8364;&#8220;40 h, filter washed processed immunoblotting guinea pig anti- <br />                                           insulin peroxidase-conjugated secondary antibody previously described (1). CPY <br />                                           secretion cells detected filter overlay overnight growth cells described <br />                                           (18) using mouse mAb anti-CPY (Molecular Probes, 1:4000 dilution) peroxidase- <br />                                           conjugated secondary antibody (Jackson ImmunoResearch, 1:10000 dilution). <br />  <br />                               Bioactive Alpha Factor Proalpha Factor Secretion <br />                                           Assay secretion bioactive alpha factor described (19). MAT&#206;&#177; cells (0.015 <br />                                           OD600/1.5 &#206;&#188;l) spotted lawn MATa bar1 cells (LM23&#226;&#8364;&#8220;3az; Ref. 20) on <br />                                           synthetic complete medium. After 1&#226;&#8364;&#8220;2 days 30 &#194;&#176;C, halos surrounding patches cells were <br />                                           visualized placing plates directly scanner converting digital images. Halo areas <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           quantified using Image Quant v5.2 (Molecular Dynamics, Inc.). <br />  <br />                                           To examine secretion proalpha factor, cells grown mid-log phase synthetic <br />                                           complete medium methionine cysteine. Cells harvested resuspended at <br />                                           0.8 OD600/ml fresh medium 1 mg/ml bovine serum albumin. 500 &#206;&#188;Ci 35S amino <br />                                           acid mixture (Expre35S35S, PerkinElmer Life Sciences) added sample, and <br />                                           incubation continued 50 min room temperature shaking. Medium separated <br />                                           cells centrifugation 19,500 &#195;&#8212; g 5 min. SDS added medium final <br />                                           concentration 1%, samples boiled 3 min. Secretion alpha factor-containing <br />                                           peptides recovered immunoprecipitation RW1 rabbit polyclonal anti-alpha <br />                                           factor antibody (kind gift Dr. D. Shields, Albert Einstein College Medicine, Bronx, NY) <br />                                           analyzed SDS-15%-PAGE fluorography. <br />  <br />  <br />  <br />  <br />                                              J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                  Page 4 <br />  <br />  <br />                               Western Blot <br />                                            Steady-state levels mycLte1p, Ste3-Myc, Kex2p analyzed cell lysates prepared <br />                                            mid-log cultures vortexing glass beads, described previously (21). Sample <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            loading normalized lysate protein measured BCA protein assay (Pierce). After <br />                                            SDS-PAGE electrotransfer nitrocellulose, blots probed anti-Myc (rabbit <br />                                            polyclonal A-14; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) anti-Kex2p (rabbit <br />                                            polyclonal M120D; gift Dr. R Fuller, University Michigan) peroxidase-conjugated <br />                                            secondary antibody (Jackson ImmunoResearch, 1:5000 dilution). Bands visualized by <br />                                            enhanced chemiluminescence (Amersham Biosciences). <br />  <br />                               Metabolic Labeling Immunoprecipitation CPY <br />                                            Metabolic labeling performed using cultures grown mid-log phase synthetic complete <br />                                            medium methionine cysteine. Cells resuspended 1 OD600/ml, labeled with <br />                                            Expre35S35S 0.1 mCi 1 OD600 cells 5 min room temperature, chased the <br />                                            presence 10 mM unlabeled methionine cysteine. At various chase times, aliquots were <br />                                            placed ice presence 10 mM sodium azide. Lysates prepared resuspended <br />                                            radioimmune precipitation assay buffer (10 mM Tris, pH 7.5, 150 nM NaCl, 2 mM EDTA, <br />                                            1% Nonidet P-40, 1% deoxycholate, 0.1% SDS) immunoprecipitation 1 &#206;&#188;l mouse <br />                                            mAb anti-CPY protein G-Sepharose beads. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Endocytic Degradation Ste3p <br />                                            As previously described (22), strains carrying pSL2015 (GAL-STE3-myc) grown mid- <br />                                            log phase synthetic complete medium containing 2% galactose sole carbon source to <br />                                            stimulate expression Ste3p-myc. At time 0, glucose (3%) added arrest further <br />                                            Ste3-myc synthesis. At indicated times glucose addition, cells harvested, and <br />                                            lysate prepared SDS-PAGE Western blotting anti-Myc antibody. <br />  <br />                               RESULTS <br />                               Identification eis4 lte1 <br />                                            The insulin secretory phenotype eis4 mutant strong eis <br />                                            mutants proved vps mutants (1). By sequencing genomic DNA adjacent lacZ <br />                                            insertion, eis4 mutant caused disruption LTE1. Full-length Lte1p is <br />                                            1435 amino acids, residues 1292&#226;&#8364;&#8220;1315 critical CDC25 homology domain that <br />                                            thought guanine nucleotide exchange activity. We lacZ/LEU2 insertion <br />                                            eis4 yielded possibility expression Lte1p gene product C-terminally truncated <br />                                            residue 783. To test effect losing C-terminal region Lte1p protein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            processing secretory pathway, prepared plasmid vectors, bearing N- <br />                                            terminally Myc-tagged version Lte1p control GAL1 promoter. We ultimately <br />                                            concentrated constructs, encoding full-length Lte1p second encoding an <br />                                            Lte1p1012 C-terminally truncated residue 1012. These forms expressed in <br />                                            cells stable proteins detected Western blotting anti-Myc antibody (Fig. 1A), the <br />                                            functionality proteins tested (Fig. 1B, below). <br />  <br />                                            Haploid yeast glucose, galactose, raffinose plates grow 13 &#194;&#176;C, either <br />                                            eis4 cells (lte1783, data shown) lte11012 cells exhibit significant low temperature growth <br />                                            phenotype regardless carbon source (middle sector, Fig. 2A). Full-length mycLte1p could <br />                                            restore low temperature growth lte11012 cells galactose raffinose plates, on <br />                                            glucose plates mycLte1p expression remains repressed (left sector, Fig. 2A). Using <br />                                            serial dilution, full-length mycLte1p expression restored quantitatively normal growth to <br />                                            lte1&#206;&#8221; cells 13 &#194;&#176;C, mycLte11012 complement growth defect (Fig. <br />  <br />  <br />                                               J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                  Page 5 <br />  <br />  <br />                                           2B). Likewise, enhanced secretion exogenously expressed immunoreactive insulin in <br />                                           lte1783 cells complemented mycLte1p (Fig. 1B). Thus, C-terminal truncation <br />                                           Lte1p supports low temperature growth normal handling insulin precursor, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           mycLte1p fully functional capacities (Figs. 1 2). <br />  <br />                               Defect Proalpha Factor Processing lte1 Mutant Cells <br />                                           To test Lte1p influences processing endogenous secretory protein substrate, we <br />                                           checked ability lte11012 cells produce bioactive alpha mating factor, assessed by <br />                                           ability cause growth arrest cells opposite mating type (20). When spotted a <br />                                           lawn Mata cells galactose plates 30 &#194;&#176;C, wild-type &#206;&#177; cells surrounded large <br />                                           halo growth-arrested Mata cells. By contrast, lte1&#206;&#8221; cells exhibited decrease halo <br />                                           area (Fig. 3A) averaged 35% reduction numerous experiments. These data suggest <br />                                           Lte1p assists production bioactive alpha factor processing insulin- <br />                                           containing fusion protein (1). Notably, substrates require cleavage Kex2p their <br />                                           maturation secretory pathway proalpha factor requires additional processing <br />                                           events generate bioactive alpha factor. <br />  <br />                                           Whereas number vps mutants impair Kex2p-mediated secretory proprotein cleavage via <br />                                           accelerated delivery Kex2p degradative compartment resulting decreased Kex2p <br />                                           levels, vps mutants subtly influence processing enzymes significant <br />                                           change Kex2p levels (such vps8 (3) vps21 (this report)). It to <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           note steady state Kex2p levels significantly affected loss expression of <br />                                           Lte1p (Fig. 3B). There small reproducible increase secretion unprocessed <br />                                           proalpha factor medium lte11012 mutant cells, comparable vps8 cells (Fig. <br />                                           3C). (For comparison, Fig. 3, B C vps21 mutant cells exhibit proalpha <br />                                           factor secretion significant decrease Kex2p level, kex2&#206;&#8221; cells exhibit <br />                                           massive proalpha factor secretion undetectable Kex2p.) <br />  <br />                                           Because Lte1p exhibits positive regulation Tem1p, small GTPase essential mitosis <br />                                           (7), wished determine secretory protein processing defect lte1 cells might <br />                                           secondary alteration cell growth. To check this, examined whether <br />                                           overexpression Tem1p suppress protein processing defect lte11012 cells. As <br />                                           shown Fig. 4B, overexpression Tem1p allowed lte1 cells grow like wild type 13 &#194;&#176; <br />                                           C, previously reported (8). Importantly, however, Tem1p overexpression did suppress <br />                                           alpha factor secretion defect lte1 (Fig. 4A, left). These data suggest impaired <br />                                           secretory protein processing lte1 cells secondary defect cell growth. <br />  <br />                               lte1 Mutant Cells Do Not Exhibit vps Phenotype <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           LTE1 known vacuolar protein sorting (VPS) gene (23), eis mutants <br />                                           known vps mutants (1), checked secretion CPY lte1 cells (Fig. 5A). Unlike <br />                                           established vps mutants (e.g. vps4 vps23), lte1 mutant cells exhibited augmented <br />                                           CPY secretion filter overlay assay (Fig. 5A). A sensitive immunoprecipitation assay <br />                                           media bathing lte1 cells demonstrated inconsequential secretion newly synthesized <br />                                           CPY (Fig. 5B). We considered possibility delayed delivery precursor CPY the <br />                                           endosomal/vacuolar frank CPY secretion lte1 cells. To check this, cells <br />                                           pulse-labeled 35S amino acids 5 min, washed, chased various times at <br />                                           30 &#194;&#176;C (Fig. 5C). At 5 min chase, P1 form CPY (in endoplasmic reticulum) <br />                                           predominated P2 (Golgi) mature (vacuolar) forms apparent. By 10 min <br />                                           chase, majority newly synthesized CPY processed mature <br />                                           form 30 min chase, processing appeared complete. In lte11012 mutant cells exhibit <br />                                           small alpha factor halo, delay appearance mature CPY, indicating that <br />                                           general protein trafficking endosomal substantially perturbed (Fig. <br />  <br />  <br />                                              J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                 Page 6 <br />  <br />  <br />                                           5C). Further, checked endocytic internalization degradation cell surface a- <br />                                           factor receptor, Ste3p, using &#226;&#8364;&#339;GAL-shut-off &#226;&#8364;? assay (22). Specifically, expression Myc- <br />                                           tagged Ste3p GAL1 control shut addition glucose, vacuolar delivery and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           degradation pre-existing cell surface receptors followed Western blotting with <br />                                           anti-Myc. As shown Fig. 6, Ste3p degraded lte11053 mutant cells normal kinetics. <br />                                           Thus, lte1 vps mutant, showing global defects endosomal trafficking. <br />  <br />                               Genetic Interactions LTE1 VPS21, Yeast Homolog Mammalian Rab 5 <br />                                           While functioning positive regulator Tem1p, Lte1p physically <br />                                           associate Ras2p-GTP manner dependent C-terminal GEF-like domain of <br />                                           Lte1p (10). To consider related GTPases involved secretory protein <br />                                           processing, BLASTp search yeast proteins performed using full-length Tem1p the <br />                                           query sequence, yielding list small GTPases shown Table 3. Overall sequence <br />                                           similarity highest Vps21p (the yeast homolog mammalian Rab5), the <br />                                           conserved GTPase domain itself, high degree similarity GTPases listed. <br />                                           Plasmid vectors overexpressing yeast gene products shown Table 3 were <br />                                           transformed Mat&#206;&#177; lte1 mutant cells test suppression alpha factor halo defect. <br />                                           As noted above, Tem1p overexpression restore normal alpha factor halo lte1 <br />                                           mutant cells (Fig. 4A), indeed, overexpression Ras2p dozen <br />                                           GTPases listed lower portion Table 3 (data shown). However, VPS21 <br />                                           overexpression, driven promoter high copy plasmid (Fig. 7A) a <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           strong constitutive (TDH3) promoter centromeric plasmid (not shown), rescue the <br />                                           alpha factor halo defect lte1 mutant cells. The effect specific, overexpression of <br />                                           Vps21p increase halo wild-type yeast, restore halo defect of <br />                                           unrelated vps23 mutant (Fig. 7A). The abnormally enhanced immunoreactive insulin <br />                                           secretion lte1 cells suppressed overexpression Vps21p (Fig. 7B). <br />  <br />                                           We looked synthetic interaction vps21 lte1 mutants. Indeed, side- <br />                                           by-side comparison plates, vps21 mutant cells alpha factor halo that <br />                                           smaller wild-type cells, lte1 vps21 double mutant clearly synthetic <br />                                           effect, alpha factor halo smaller mutant (Fig. 8A). Such a <br />                                           synthetic effect observed vps mutants tested; e.g. lte1 vps9 <br />                                           (an established GEF Vps21p GTPase, Ref. 24) showed additive inhibition (reduction) <br />                                           alpha halo (Fig. 8B). Notably, lte1 vps21 double mutant cells major decrease in <br />                                           steady state levels Kex2p (Fig. 3B), exhibit synthetic increase secretion <br />                                           unprocessed proalpha factor (Fig. 3C). Thus, data support interaction VPS21 with <br />                                           LTE1 secretory pro-protein processing. <br />  <br />                               VPS21 Genetically Interacts lte1 Mitosis Different Way Than Secretory <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Proprotein Processing <br />                                           Given specificity Tem1p GTPase mitotic spindle pole checkpoint, no <br />                                           reason expect overexpression Vps21p, rescues alpha factor halo defect of <br />                                           lte1 cells, impact low temperature growth lte1 mutant cells. It therefore <br />                                           surprising discover VPS21 expressed promoter multicopy <br />                                           plasmid, lte11012 mutant cell growth longer arrested 13 &#194;&#176;C (Fig. 9A). Also, when <br />                                           VPS21 expressed strong constitutive promoter centromeric plasmid, rescued <br />                                           growth lte1&#206;&#8221; cells comparably TEM1 expressed promoter (Fig. <br />                                           9B). <br />  <br />                                           To explore interactions VPS21 lte1, used semipermissive low <br />                                           temperature 17 &#194;&#176;C examine growth vps21 lte1, vps21 lte1 double mutant cells. <br />                                           At 25 &#194;&#176;C, strains grew like VPS21 LTE1 wild type (Fig. 10A, left). At 17 &#194;&#176;C, <br />  <br />  <br />                                              J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                               Page 7 <br />  <br />  <br />                                          mitotic blockade lte1 cells demonstrated partial growth defect, growth <br />                                          vps21 lte1 double mutant cells profoundly inhibited (Fig. 10B). Growth vps21 <br />                                          mutant inhibited conditions (Fig. 10B). These data provide <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          good genetic evidence presence Vps21p, endogenous expression levels, <br />                                          limits mitotic defect lte1 mutant cells. By contrast, shown Fig. 10C, vps9 did not <br />                                          exert appreciable growth phenotype combined lte1 mutant, suggesting that <br />                                          GEF activity Vps9p important Vps21p play role Lte1p function. <br />  <br />                                          To distinguish suppressor effects Vps21p secretory protein processing defect of <br />                                          lte1 cells versus suppression low temperature growth arrest lte1, compared the <br />                                          effect overexpressing inactive (persistently GDP-bound) Vps21p-S21L mutant versus <br />                                          constitutively active (persistently GTP-bound) Vps21p-Q66L mutant. As measured by <br />                                          Western blotting (not shown), protein expression level recombinant Vps21p <br />                                          mutant identical, equivalent cells overexpressing wild-type Vps21p. <br />                                          Using strains, apparent rescue alpha factor halo defect lte11012 cells <br />                                          achieved overexpressing persistently GTP-bound Vps21p-Q66L mutant, whereas <br />                                          GDP-bound Vps21p-S21L mutant devoid activity (Fig. 11, left panel). <br />  <br />                                          In contrast behavior, overexpressing persistently GDP-bound Vps21p-S21L <br />                                          mutant exhibited similar degree suppression growth arrest phenotype lte1 cells <br />                                          13 &#194;&#176;C overexpressing wild-type Vps21p constitutive active Vps21p-Q66L <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          mutant (Fig. 11, right panel). These data strongly suggest differences VPS21-mediated <br />                                          suppression mutant phenotypes lte1 cells: suppression secretory protein processing <br />                                          defect specifically requires active GTP-bound Rab, rescue low temperature <br />                                          growth arrest does require GTP-loading overexpressed Vps21p. <br />  <br />                               DISCUSSION <br />                                          Lte1p low temperature essential gene product allows yeast cells advance through <br />                                          end mitosis regulated small GTPase Tem1p. It debated CDC25 <br />                                          homology (GEF) domain contained C-terminal region Lte1p normally required for <br />                                          mitotic function (10) currently favored view (11). TEM1 originally <br />                                          discovered screen high copy suppressor genes rescue cold-sensitive growth arrest <br />                                          lte1 cells (8). Tem1p expression turned mitosis, acts essential <br />                                          controller mitotic exit network. The timing Tem1p activation Lte1p occurs when <br />                                          spindle pole body migrates bud. Lte1p localization bud appears regulated <br />                                          interactions Ras2p (10), phosphorylation state (11), interactions cell <br />                                          polarity proteins (14). However, Lte1p function S-phase largely unknown. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          We identified lte1 eis4, screen yeast mutants exhibit enhanced insulin <br />                                          secretion defects secretory protein processing (1). The eis group mutants <br />                                          appears work impairing recycling secretory protein processing enzymes (e.g. <br />                                          Kex2p, Ste13p, Kex1p) Golgi endosomal systems (1). In study we <br />                                          confirm original observations eis4 (which hypothetically produces protein containing <br />                                          783 residues Lte1p). Specifically, demonstrate eis4 phenotype is <br />                                          complemented full-length mycLte1p (Fig. 1). Moreover, demonstrate proprotein <br />                                          processing defect lte1 mutant cells ranging complete null lte11012 mutant that <br />                                          lacks C-terminal GEF domain. This truncation mutant exhibits classic low temperature <br />                                          growth arrest, conditions truncated Lte11012 protein stably expressed, <br />                                          rescue low temperature growth lte1&#206;&#8221; cells (Fig. 2). The lte11012 mutant produces <br />                                          bioactive alpha factor judged reproducibly smaller alpha factor halo increase <br />                                          secretion unprocessed proalpha factor. The data suggest C-terminal GEF <br />                                          domain Lte1p involved role secretory protein processing. The phenotype is <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                Page 8 <br />  <br />  <br />                                          mild, resulting significant change intracellular Kex2p level, comparable certain <br />                                          vps mutants (Fig. 3). Nevertheless, lte1 vps mutant, exhibiting defect the <br />                                          trafficking vacuolar carboxypeptidase Y (Fig. 5) defect endocytic internalization <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          degradation cell surface Ste3p (Fig. 6). These results compatible growing list <br />                                          mutants trafficking genes affect Golgi-early endosomal trafficking secretory <br />                                          proprotein processing produce vps phenotype, tlg2 (and large extent, <br />                                          tlg1 (25), chc1 (26), inp53 (27,28)). As intracellular site Vps21p function <br />                                          involves Golgi-early endosome trafficking (29), Lte1p facilitate Vps21p activity this <br />                                          site; lte1 considered candidate addition foregoing list mutants. <br />  <br />                                          During S-phase, Lte1p unlikely work Tem1p activation Tem1p expression is <br />                                          limited phase cell cycle (12). Indeed, unlike low temperature growth <br />                                          defect, secretory protein processing phenotype lte1 rescued overexpression <br />                                          TEM1 (Fig. 4). One argue multicopy expression (Fig. 4), TEM1 cannot <br />                                          suppress alpha factor halo defect lte1 mutant cells cell cycle-dependent <br />                                          regulation limits Tem1p availability. However, TEM1 promoter replaced the <br />                                          strong constitutive TDH3 promoter, TDH3-TEM1 rescue alpha factor halo <br />                                          defect lte1 cells (not shown). Moreover, overexpression Ras2p, Ras1p, 11 <br />                                          GTPases effect secretory protein processing (Table 3), suggesting Lte1p <br />                                          unlikely work GTPases secretory protein processing. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          By contrast, VPS21, overexpressed lte1 mutant cells, restored production bioactive <br />                                          alpha mating factor (as measured halo assay) restored normal of <br />                                          immunoreactive insulin secretion (Fig. 7). This effect quite specific, insofar VPS21 <br />                                          overexpression increase secretory protein processing wild-type yeast vps <br />                                          mutants bearing unrelated genetic defects (Fig. 7). Moreover, vps21&#206;&#8221; exhibited synthetic <br />                                          defect secretory protein processing lte1, synthetic defect be <br />                                          mimicked deletion particular Vps21p GEF, vps9 (Fig. 8). The results provide genetic <br />                                          evidence LTE1 interacts VPS21 manner independent VPS9. (Intriguingly <br />                                          lte1 mutant cells, synthetic defect exhibited vps21&#206;&#8221; mimicked several <br />                                          vps mutants tested, including vps4, vps23, pep12 (not shown), implying activity <br />                                          recycling proprotein processing enzymes endosomal system.) Whereas <br />                                          explanations possible, simple hypothesis Lte1p function GEF <br />                                          Vps21p endocytic secretory subcompartment cells S-phase. <br />                                          Certainly rapidly expanding number potential GEFs identified appear <br />                                          support Vps21p GTPase mammalian homolog, Rab 5 (24). <br />  <br />                                          A finding surprising (and believe, quite distinct described above) was <br />                                          overexpression VPS21, previously implicated mitosis, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          rescued low temperature growth lte1 mutant cells (Fig. 9). This true both <br />                                          lte1&#206;&#8221; cells cells bearing lte11012 truncation. Furthermore, vps21&#206;&#8221; exhibited a <br />                                          synthetic growth defect lte1 17 &#194;&#176;C, genetic interaction lte1 mitosis could <br />                                          mimicked merely cutting VPS9-mediated GEF activity Vps21p (Fig. 10). We <br />                                          propose unusual mitotic effects derive structural similarities between <br />                                          Vps21p Tem1p (Table 3). Whereas reason believe Vps21p plays a <br />                                          specific role mitosis, hypothesize Vps21p compete certain interaction <br />                                          partners, GAP (GTPase-activating) proteins tonically inhibit Tem1p by <br />                                          converting protein active GTP-bound form inactive GDP-bound form. The <br />                                          recruitment proteins Vps21p increase activity Tem1p, <br />                                          facilitating low temperature mitotic progression lte1 background. Alternatively, VPS21 <br />                                          activity endosomal trafficking theoretically facilitate localization more <br />                                          anchoring proteins regulators mitotic exit network, enhancing Tem1p <br />                                          activation spindle pole body checkpoint. However, favor hypothesis <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                               Page 9 <br />  <br />  <br />                                          rescue low temperature growth lte1 mutant cells achieved by <br />                                          overexpressing inactive, persistently GDP-bound, Vps21p-S21L mutant (Fig. 11). <br />                                          Altogether, findings underscore secretory protein processing defect lte1 mutant cells, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          rescue specifically requires overexpressing active Vps21p achieve the <br />                                          GTP-bound state (Fig. 11). <br />  <br />                               Acknowledgements <br />                                          We thank members Arvan Chang laboratories helpful discussions. <br />  <br />  <br />                               References <br />                                          1. Zhang, B-y; Chang, A.; Kjeldsen, TB.; Arvan, P. J Cell Biol 2001;153:1187&#226;&#8364;&#8220;1197. [PubMed: <br />                                              11402063] <br />                                          2. Zhang, B-y; Liu, M.; Arvan, P. J Biol Chem 2003;278:3687&#226;&#8364;&#8220;3693. [PubMed: 12446709] <br />                                          3. Luo W, Chang A. J Cell Biol 1997;138:731&#226;&#8364;&#8220;746. [PubMed: 9265642] <br />                                          4. Johnston HD, Foote C, Santeford A, Nothwehr SF. Mol Biol Cell 2005;16:1456&#226;&#8364;&#8220;1468. [PubMed: <br />                                              15647379] <br />                                          5. Wickner RB, Koh TJ, Crowley JC, O&#226;&#8364;&#8482;Neil J, Kaback DB. Yeast 1987;3:51&#226;&#8364;&#8220;57. [PubMed: 3332963] <br />                                          6. Molk JN, Schuyler SC, Liu JY, Evans JG, Salmon ED, Pellman D, Bloom K. Mol Biol Cell <br />                                              2004;15:1519&#226;&#8364;&#8220;1532. [PubMed: 14718561] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          7. Jensen S, Johnson AL, Johnston LH, Segal M. Cell Cycle 2004;3:817&#226;&#8364;&#8220;822. [PubMed: 15197338] <br />                                          8. Shirayama M, Matsui Y, Toh-e A. Yeast 1994;10:451&#226;&#8364;&#8220;461. [PubMed: 7941731] <br />                                          9. Jensen S, Geymonat M, Johnson AL, Segal M, Johnston LH. J Cell Sci 2002;115:4977&#226;&#8364;&#8220;4991. [PubMed: <br />                                              12432084] <br />                                          10. Yoshida S, Ichihashi R, Toh-e A. J Cell Biol 2003;161:889&#226;&#8364;&#8220;897. [PubMed: 12782684] <br />                                          11. Seshan A, Amon A. Cell Cycle 2005;4:940&#226;&#8364;&#8220;946. [PubMed: 15917658] <br />                                          12. Bardin AJ, Visintin R, Amon A. Cell 2000;102:21&#226;&#8364;&#8220;31. [PubMed: 10929710] <br />                                          13. Lord M, Yang MC, Mischke M, Chant J. J Cell Biol 2000;151:1501&#226;&#8364;&#8220;1512. [PubMed: 11134078] <br />                                          14. Hofken T, Schiebel E. EMBO J 2002;21:4851&#226;&#8364;&#8220;4862. [PubMed: 12234925] <br />                                          15. Sherman, F.; Hicks, JB.; Fink, GR. A Laboratory Manual. Cold Spring Harbor Laboratory Press; <br />                                               Cold Spring Harbor, NY: 1986. <br />                                          16. Sikorski RS, Hieter P. Genetics 1989;122:19&#226;&#8364;&#8220;27. [PubMed: 2659436] <br />                                          17. Warner JR. Methods Enzymol 1991;194:423&#226;&#8364;&#8220;428. [PubMed: 2005801] <br />                                          18. Roberts CJ, Raymond CK, Yamashiro CT, Stevens TH. Methods Enzymol 1991;194:644&#226;&#8364;&#8220;661. <br />                                               [PubMed: 1706462] <br />                                          19. Sprague GFJ. Methods Enzymol 1991;194:77&#226;&#8364;&#8220;93. [PubMed: 2005823] <br />                                          20. Marsh L. Mol Cell Biol 1992;12:3959&#226;&#8364;&#8220;3966. [PubMed: 1324410] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          21. Chang A, Slayman CW. J Cell Biol 1991;115:289&#226;&#8364;&#8220;295. [PubMed: 1833410] <br />                                          22. Davis ND, Horecka JL, Sprague GFJ. J Cell Biol 1993;122:53&#226;&#8364;&#8220;65. [PubMed: 8391002] <br />                                          23. Bonangelino CJ, Chavez EM, Bonifacino JS. Mol Biol Cell 2002;13:2486&#226;&#8364;&#8220;2501. [PubMed: <br />                                               12134085] <br />                                          24. Carney DS, Davies BA, Horazdovsky BF. Trends Cell Biol 2006;16:27&#226;&#8364;&#8220;35. [PubMed: 16330212] <br />                                          25. Holthuis JC, Nichols BJ, Dhruvakumar S, Pelham HR. EMBO J 1998;17:113&#226;&#8364;&#8220;126. [PubMed: <br />                                               9427746] <br />                                          26. Yeung BG, Phan HL, Payne GS. Mol Biol Cell 1999;10:3643&#226;&#8364;&#8220;3659. [PubMed: 10564262] <br />                                          27. Bensen ES, Costaguta G, Payne GS. Genetics 2000;154:83&#226;&#8364;&#8220;97. [PubMed: 10628971] <br />                                          28. Ha SA, Torabinejad J, DeWald DB, Wenk MR, Lucast L, De Camilli P, Newitt RA, Aebersold R, <br />                                               Nothwehr SF. Mol Biol Cell 2003;14:1319&#226;&#8364;&#8220;1333. [PubMed: 12686590] <br />                                          29. Singer-Kruger B, Stenmark H, Zerial M. J Cell Sci 1995;108:3509&#226;&#8364;&#8220;3521. [PubMed: 8586662] <br />                                          30. Thomas BJ, Rothstein R. Cell 1989;56:619&#226;&#8364;&#8220;630. [PubMed: 2645056] <br />  <br />  <br />  <br />                                              J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                 Page 10 <br />  <br />  <br />                                          31. Singer-Kruger B, Stenmark H, Dusterhoft A, Philippsen P, Yoo JS, Gallwitz D, Zerial M. J Cell Biol <br />                                              1994;125:283&#226;&#8364;&#8220;298. [PubMed: 8163546] <br />                                          32. Walworth NC, Brennwald P, Kabcenell AK, Garrett M, Novick P. Mol Cell Biol 1992;12:2017&#226;&#8364;&#8220;2028. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              [PubMed: 1569938] <br />                                          33. Jedd G, Mulholland J, Segev N. J Cell Biol 1997;137:563&#226;&#8364;&#8220;580. [PubMed: 9151665] <br />                                          34. Ohya Y, Qadota H, Anraku Y, Pringle JR, Botstein D. Mol Biol Cell 1993;4:1017&#226;&#8364;&#8220;1025. [PubMed: <br />                                              8298188] <br />                                          35. Matsui Y, Toh-E A. Mol Cell Biol 1992;12:5690&#226;&#8364;&#8220;5699. [PubMed: 1448099] <br />                                          36. Powers S, Kataoka T, Fasano O, Goldfarb M, Strathern J, Broach J, Wigler M. Cell 1984;36:607&#226;&#8364;&#8220; <br />                                              612. [PubMed: 6365329] <br />                                          37. Li B, Warner JR. J Biol Chem 1996;271:16813&#226;&#8364;&#8220;16819. [PubMed: 8663225] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                             Page 11 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 1. Expression Myc-tagged Lte1p functionality full-length construct in <br />                                          restoring normal cellular handling insulin-containing fusion protein <br />                                          A, cells grown liquid medium 2% raffinose (to allow expression GAL1 <br />                                          promoter) lysed analyzed expression full-length mycLte1p mycLte11012 by <br />                                          Western blot, normalized equal total cell protein. Molecular mass estimated mobility <br />                                          molecular weight markers shown right. B, filter blot assay immunoreactive insulin <br />                                          secretion plates containing 2% galactose. The lte1 mutant shown figure eis4 <br />                                          mutant described previously (1) insertional mutagenesis results Lte1p truncated <br />                                          773 residues. All eis mutants impair proprotein processing, resulting enhanced <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                        Page 12 <br />  <br />  <br />                                          immunoreactive insulin secretion (1), expression full-length mycLte1p restores the <br />                                          insulin secretion levels seen wild-type (wt) cells. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                             Page 13 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 2. Low temperature growth defect lte11012 lte1 null (lte1&#206;&#8221;) cells rescued by <br />                                          expression mycLte1p <br />                                          A, wild-type (wt) lte11012 cells transformed pYES2 high copy <br />                                          expression plasmid; lte11012 mutant cells grow efficiently 13 &#194;&#176;C carbon <br />                                          source. However, lte11012 cells expressing mycLte1p GAL1 promoter pYES2 grew <br />                                          normally galactose (in GAL1 promoter strongly stimulated) raffinose (in <br />                                          GAL1 promoter strongly stimulated). B, quantitative growth assay galactose <br />                                          plates wild-type (wt) yeast growth compared lte1&#206;&#8221; yeast, lte1&#206;&#8221; bearing <br />                                          full-length mycLte1p (third line) mycLte1p1012 (bottom line). Each line contains identical <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 14 <br />  <br />  <br />                                          volume yeast starting identical OD, spotted sequential 10-fold serial dilutions from <br />                                          left right. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                             Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 3. Defective production biologically active alpha mating factor lte1 cells <br />                                          A, alpha factor halo lawn cells LM23&#226;&#8364;&#8220;3a (MATa bar1). The lte1&#206;&#8221; cells exhibit a <br />                                          37.7 &#194;&#177; 1.8% reduction alpha factor halo area. This experiment reproduced with <br />                                          replicates independent experiments. B, Western blot steady state Kex2p levels, <br />                                          normalized total cellular protein, lte11012 mutant cells, vps21&#206;&#8221; cells, lte11012 vps21&#206;&#8221; <br />                                          double mutant cells. The result kex2&#206;&#8221; strain provided negative control, left. <br />                                          C, secretion immunoreactive alpha factor strains shown B, vps8 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          cells. Each strain grown mid-log phase. Identical OD units cells labeled <br />                                          35S amino acids described &#226;&#8364;&#339;Experimental Procedures,&#226;&#8364;? medium collected. <br />                                          Immunoprecipitates medium anti-alpha factor antibody analyzed by <br />                                          SDS-PAGE fluorography. A background band seen wild-type (wt) cells just below <br />                                          proalpha factor migration position. A kex2&#206;&#8221; strain analyzed right; presence <br />                                          high molecular mass proalpha factor band indicates deficiency Kex2p activity. Other <br />                                          secretory protein processing activities deficient vps mutant strains. The <br />                                          appearance band the gel comigrates mature alpha factor a <br />                                          useful control total proalpha factor expression strains, does not <br />                                          mean material biologically active, additional Kex2p, Ste13p, Kex1p <br />                                          cleavages required produce bioactive alpha factor low molecular mass <br />                                          inactive intermediates (23) resolved dye SDS-PAGE <br />                                          conditions shown here. <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                              Page 16 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 4. High copy TEM1 expression (8) lte11012 cells: effects secretory protein processing <br />                                          low temperature growth <br />                                          A, alpha factor halo assay (cells grown 30 &#194;&#176;C). The alpha factor halo area 64.2 &#194;&#177; 9.4% <br />                                          lte11012 cells 48.2 &#194;&#177; 1.5% lte11012 cells high copy expression TEM1. B, <br />                                          growth 13 &#194;&#176;C. Note TEM1 overexpression rescues low temperature growth, it <br />                                          induce recovery production bioactive alpha factor. <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 5. Lack vps phenotype lte11012 mutant cells <br />                                          A, filter overlay immunoreactive CPY secretion selected strains (vps4 vps23 shown <br />                                          positive controls; wild-type yeast (WT) negative control). B, 30 min continuous <br />                                          labeling indicated strains 35S amino acids, followed immunoprecipitation of <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          labeled cells media anti-CPY antibody. The immunoprecipitates analyzed by <br />                                          SDS-PAGE phosphorimaging. While vps21 cells secrete CPY precursor, sorting of <br />                                          CPY lte1 mutant cells appears similar wild-type yeast (WT). C, 25 &#194;&#176;C, wild-type <br />                                          (LTE1) mutant (lte11012) cells labeled 5 min 35S amino acids chased <br />                                          number minutes indicated panel. Cell lysates prepared and <br />                                          immunoprecipitated anti-CPY antibody, analyzed SDS-PAGE and <br />                                          fluorography demonstrate intracellular maturation kinetics CPY precursor. The positions <br />                                          endoplasmic reticulum P1 form, Golgi P2 form, vacuolar mature form CPY are <br />                                          indicated, right. <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 18 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 6. Endocytic degradation Ste3p <br />                                          Wildtype (WT) lte111012 strains transformed pSL2015 (GAL1-STE3-myc). <br />                                          Endocytic degradation Ste3p-Myc analyzed described &#226;&#8364;&#339;Experimental <br />                                          Procedures.&#226;&#8364;? At times indicated, aliquot yeast removed analyzed <br />                                          Western blot. Time 0 represents steady-state level Ste3 addition glucose <br />                                          final concentration 3%. The blot probed anti-Myc; position Myc-tagged <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Ste3p indicated left. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                              Page 19 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 7. Overexpression VPS21 rescues secretory protein processing defect lte11012 <br />                                          mutant cells <br />                                          A, wild-type (wt) cells lte11012 cells transformed plasmid pYPT51. The alpha <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          factor halo defect lte1 mutant cells (52.5% wild-type cells) selectively rescued <br />                                          (to 95.3%) overexpression VPS21 (but small GTPases listed Table <br />                                          3). Note VPS21 overexpression did enlarge normal halo wild-type cells, <br />                                          did normalize small halo unrelated (vps23) mutant. B, filter blot for <br />                                          immunoreactive insulin wild-type (wt) lte1773 (eis4) mutant cells transformed with <br />                                          vector, multicopy VPS21. Note abnormally eis phenotype lte1 mutant cells is <br />                                          improved (diminished) overexpression VPS21. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 20 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 8. Synthetic effects lte11012 vps21&#206;&#8221; double mutant lte11012 vps9 double mutant <br />                                          A, wild-type yeast (WT) mutant MAT&#206;&#177; tester strains indicated spotted a <br />                                          lawn LM23-3a (MATabar1) cells duplicate single plate. The results shown were <br />                                          replicated independent experiments. Note single lte1 vps21 mutants <br />                                          modest deficiencies bioactive alpha factor production; lte1 vps21 double mutant <br />                                          exhibited major reduction halo size (28.3 &#194;&#177; 11.3% wild-type cells), indicating a <br />                                          synthetic defect. B, above, combining lte1 vps9 mutants. Although the <br />                                          single vps9 mutant small halo, inhibitory effects production bioactive alpha <br />                                          factor additive inhibitory effect lte1 mutant. <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 21 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 9. Overexpression VPS21 rescues low temperature growth defect lte11012 mutant <br />                                          cells <br />                                          A, growth 13 &#194;&#176;C lte11012 cells transformed vector (right sector) high <br />                                          copy plasmid bearing VPS21 (pYPT51, left sector); strain grows like wild-type yeast <br />                                          (WT). B, growth 13 &#194;&#176;C wild-type (wt) lte11012 cells transformed pRS314 <br />                                          (CEN) vector pRS314 bearing TDH3-VPS21 (pTVPS21) TDH3-TEM1(pTTEM1). <br />                                          Under conditions, overexpression VPS21 restores normal growth lte11012 cells equal <br />                                          rescue provided TEM1. <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                         Page 22 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 10. Synthetic growth defect vps21 lte11012 <br />                                          A, quantitative growth assay wild-type (VPS21 LTE1), lte1 mutant (VPS21 lte11012), <br />                                          vps21&#206;&#8221; (vps21&#206;&#8221; LTE1), double mutant (vps21&#206;&#8221; lte11012) cells 25 &#194;&#176;C. B, growth the <br />                                          strains 17 &#194;&#176;C. C, quantitative growth assay wild-type (VPS9 LTE1), lte1 mutant <br />                                          (VPS9 lte11012), vps9&#206;&#8221; (vps9&#206;&#8221; LTE1), double mutant (vps9&#206;&#8221; lte11012) cells 17 &#194;&#176;C. Each <br />                                          row contains identical volume yeast starting identical OD, pipetted sequential <br />                                          10-fold serial dilution left right. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                           Page 23 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 11. Function constitutively active GTP-bound mutant form Vps21p (Vps21p-Q66L) <br />                                          persistently GDP-bound mutant form Vps21p (Vps21p-S21L) rescue secretory <br />                                          protein processing low temperature growth defects lte11012 mutant cells <br />                                          Overexpression Vps21p mutant forms Vps21p accomplished Fig. 9B. Left <br />                                          panel, alpha factor halo assay. Right panel, quantitative growth assay strains at <br />                                          13 &#194;&#176;C. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                                    Zhao et al.                                                                                                       Page 24 <br />  <br />                                                                                      TABLE 1 <br />                            Yeast strains used study <br />  <br />                               Strains                         Genotype                                                                       Source <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               W303                            MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52                           30 <br />                               L3852                           MAT&#206;&#177; his3-200 lys2-201 leu2-3,112 ura3-52 ade2                                    3 <br />                               L5145                           Mata kss1 ura3-52 leu2-3,112 his3 trp1&#204;&#8218;63 ade2 GAL+                               3 <br />                               L4                              MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 lte11012::URA3        This study <br />                               H4                              MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 lte11012::HIS3        This study <br />                               lte1&#206;&#8221;                           MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 lte1&#206;&#8221;::HIS3           This study <br />                               vps23&#206;&#8221;                          MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 vps23&#206;&#8221;::TRP1          This study <br />                               vps8&#206;&#8221;                           MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 vps8&#206;&#8221;::URA3           This study <br />                               VPS21 lte11012                  MAT&#206;&#177; his3-200 lys2-201 leu2-3,112 ura3-52 ade2 lte11012::URA3                This studya <br />                               vps21&#206;&#8221; LTE1                     MAT&#206;&#177; his3-200 lys-201 ura3-52 leu2-3,112 ade2 vps21&#206;&#8221;::LYS2                   This studya <br />                               vps21&#206;&#8221; lte11012                 MAT&#206;&#177; his3-200 lys2-201 leu2-3,112 ura3-52 ade2 vps21&#206;&#8221;::LYS2 lte11012::URA3   This studya <br />                               vps9&#206;&#8221;                           MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 vps9&#206;&#8221;::HIS3           This study <br />                               vps9&#206;&#8221; lte11012                  MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 lte11012::URA3        This study <br />                                                               vps9&#206;&#8221;::HIS3 <br />                               BFY106-4D                       MAT&#206;&#177; ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 kex2&#206;&#8221;::HIS3-A            3 <br />                               LM23-3az                        MATa bar1 ura3 leu2 his4 trp1 met1 [FUS1-lacZ::URA3]                             20 <br />  <br />                               a <br />                                L3852L4, vps21&#206;&#8221;, vps21&#206;&#8221; lte11012 isogenic L3852. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                                  Zhao et al.                                                                                                           Page 25 <br />  <br />                                                                                    TABLE 2 <br />                            Plasmids used study <br />  <br />                              Plasmid                                 Description                                                           Source <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                              pSL2015                                 CEN URA3 GAL-STE3-myc YCp50                                           22 <br />                              pYpt51                                  2&#206;&#188; URA3 VPS21 pSEY8                                                   31 <br />                              pYpt52                                  2&#206;&#188; LEU2 YPT52 YEp13                                                   31 <br />                              pYPT53                                  2&#206;&#188; URA3 YPT53 pSEY8                                                   31 <br />                              pYEplac181-TEM1                         2&#206;&#188; LEU2 TEM1 YEplac181                                                 8 <br />                              pBB80                                   2&#206;&#188; URA3 SEC4 YEp24                                                    32 <br />                              pAC77                                   2&#206;&#188; LEU2 YPT7                                              A. Chang collection, U. Michigan <br />                              pNS455                                  2&#206;&#188; URA3 GAL-YPT32 YEp352                                              33 <br />                              pNS198                                  2&#206;&#188; URA3 GAL-YPT31 YEp24                                               33 <br />                              pRB1594                                 2&#206;&#188; LEU2 CDC42 Yep351                                                  34 <br />                              pRB1596                                 2&#206;&#188; TRP1 RHO2 pYO324                                                   34 <br />                              pRB1592                                 2&#206;&#188; TRP1 RHO1 pYO324                                                   34 <br />                              pYO324-RHO4                             2&#206;&#188; TRP1 RHO4 pYO324                                                   35 <br />                              YEpRas1                                 2&#206;&#188; LEU2 RAS1                                                             36 <br />                              YEpRas2                                 2&#206;&#188; LEU2 RAS2                                                             36 <br />                              pYPT6                                   CEN URA3 YPT6 YIp5                                                    37 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                          J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                                   Zhao et al.                                                                                                       Page 26 <br />  <br />                                                                                        TABLE 3 <br />                            Small GTPases similarity Tem1p tested suppression protein processing defect lte1 mutant cells <br />  <br />                              GTPase                          % Overall similarity        Type plasmida                     Vector used expression <br />                          <br /> </body></html>